Healthcare Industry News: Kyphoplasty
News Release - March 6, 2012
Vexim Continues Its Development and Sets up in Germany to Directly Market the SpineJack(R) RangeCreation of Vexim GmbH, the first Vexim subsidiary
Recruitment of a dedicated sales team underway
TOULOUSE, France--(Healthcare Sales & Marketing Network)--Vexim, a Med-Tech company that specializes in minimally invasive treatment of vertebral fractures (called “minimally invasive anatomical restoration”), announces the creation of its German subsidiary in Ulme (between Stuttgart and Munich). Vexim GmbH will be responsible for promoting and marketing the SpineJack® range in Germany, in addition to training German physicians.
A sales team is currently being recruited on the local German market and will be composed of 6 sales agents fully dedicated to Vexim, and a sales director.
The German Kyphoplasty market is today estimated at €90 million and the market leader is Medtronic.
VEXIM has its own sales force in France and in Germany which works with various prescribers including clinics, hospitals, surgeons and radiologists and collaborates with distributers in Spain, Portugal, Italy, Turkey, Argentina and South Africa.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.